Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Approved HIV reverse transcriptase inhibitors in the past decade
Guangdi Li, Yali Wang, De Clercq Erik (2021). Approved HIV reverse transcriptase inhibitors in the past decade. , 12(4), DOI: https://doi.org/10.1016/j.apsb.2021.11.009.
Article58 days agoTherapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li, De Clercq Erik (2020). Therapeutic options for the 2019 novel coronavirus (2019-nCoV). , 19(3), DOI: https://doi.org/10.1038/d41573-020-00016-0.
Article58 days agoClinical significance of chemokine receptor antagonists
Miao Miao, De Clercq Erik, Guangdi Li (2020). Clinical significance of chemokine receptor antagonists. , 16(1), DOI: https://doi.org/10.1080/17425255.2020.1711884.
Article58 days agoMortality risk of COVID-19 in elderly males with comorbidities: a multi-country study
Guangdi Li, Yacong Liu, Xixi Jing, Yali Wang, Miao Miao, Tao Li, Zhiguo Zhou, Yuanlin Xie, Yaxiong Huang, Jianhua Lei, Guozhong Gong, Ping Jin, Yuantao Hao, Nuno R. Faria, De Clercq Erik, Min Zhang (2020). Mortality risk of COVID-19 in elderly males with comorbidities: a multi-country study. , 13(1), DOI: https://doi.org/10.18632/aging.202456.
Article58 days ago<p>Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in Therapy</p>
Miao Miao, Xixi Jing, De Clercq Erik, Guangdi Li (2020). <p>Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in Therapy</p>. , Volume 14, DOI: https://doi.org/10.2147/dddt.s254754.
Article58 days ago